Health

FDA Approves New Multiple Myeloma Treatment

Updated 2026-08-14 12:10 UTC 1 source Positive

The FDA has approved a new treatment for advanced multiple myeloma by Bristol Myers Squibb, marking the debut of a novel drug class in the fight against this blood cancer.

Coverage timeline — 1 article

STAT News

STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

2026-08-14 12:03 UTC